IPSS trends for Cs-131 permanent prostate brachytherapy

Cancer types prostate


Andrew Jones, Ph.D., Jared Treas, M.S., John Danella, M.D., Omar Yumen, M.D.

April 1, 2008
Dr. Jones from Danville, PA, reports on 90 patients with prostate cancer treated with Cesium-131 brachytherapy. He and his colleagues conclude that the short half-life of Cesium-131 contributes to a shorter duration of the typical urinary side-effects of brachytherapy

Related posts

Scroll to top